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Abstract
2,4,6-Tris(2-pyrimidyl)-1,3,5-triazine (TPymT) has been synthesized using two
approaches: via trimerization of 2- cyanopyrimidine at 160 °C and by the reaction
of 2-cyanopyrimidine with pyrimidine-2-carboximidamide. It was found that the
two different synthetic pathways to TPymT yielded either a single polymorph
or a mixture of two polymorphs; both of which were studied for the first time
by X-ray powder diffraction (XRPD) and synchrotron X-ray powder diffraction
(SXRPD). The crystal structure of the polymorph α-TPymT was determined by
single crystal X-ray diffraction (SCXRD). Crystal structures of 2-cyanopyrimidine
and pyrimidine-2-carboximidamide were also elucidated by SXRPD.
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2,4,6-Tris(2-pyrimidyl)-1,3,5-triazine (TPymT) has been 
synthesized using two approaches: via trimerization of 2-
cyanopyrimidine at 160 °C and by the reaction of 2-
cyanopyrimidine with pyrimidine-2-carboximidamide. It was 10 
found that the two different synthetic pathways to TPymT 
yielded either a single polymorph or a mixture of two 
polymorphs; both of which were studied for the first time by 
X-ray powder diffraction (XRPD) and synchrotron X-ray 
powder diffraction (SXRPD). The crystal structure of the 15 
polymorph α-TPymT was determined by single crystal X-ray 
diffraction (SCXRD). Crystal structures of 2-
cyanopyrimidine and pyrimidine-2-carboximidamide were 
also elucidated by SXRPD. 
2,4,6-Tris(2-pyrimidyl)-1,3,5-triazine (TPymT) has been 20 
known for about 55 years, when Case and Koft isolated the 
product with a very low yield from 2-cyanopyrimidine on 
standing for several months.1 About 20 years latter, Lerner 
and Lippard described the synthesis of TPymT from the same 
precursor with an extremely high yield.2 Although TPymT is 25 
very attractive as a potential ligand for metal complexation 
due to the presence of three fused terpyridine-like chelating 
sites, to the best of our knowledge, only a few works have 
been reported on the coordination chemistry of TPymT.3 In 
fact, until recently only two reported crystal structures 30 
involving coordination of TPymT to PbII had been 
published.3a,b This can be attributed to the sensitivity of the 
triazine fragment towards hydrolysis in the presence of metal 
cations under mild conditions.2,4 As such, the coordination 
chemistry of TPymT remains an on going challenge. With 35 
this in mind we have recently directed our attention to the 
synthesis and study of TPymT-based coordination compounds 
and, as a first step, we reported the unprecedented dinuclear 
CdII complex, [Cd2(TPymT)(H2O)6(SO4)2]·H2O.
5 Furthermore, 
we have reported a pseudo-polymorph [Pb2(TPymT)(NO3)4]n
6 40 
of a previously published lead structure.3a These polynuclear 
complexes show a glimpse of great potential of TPymT as a 
multidentate ligand. To prevent TPymT degradation through 
hydrolysis and subsequently master the coordination 
chemistry, we need to understand the stability of TPymT on 45 
its own. 
Surprisingly, the crystal structure of TPymT is still 
unknown, although its close analogues 2,4,6-tris(2-pyridyl)-
1,3,5-triazine and 2,4,6-tris(4-pyridyl)-1,3,5-triazine have 
been characterized by single crystal X-ray diffraction.7 This is 50 
likely due to the extremely poor solubility of TPymT in 
common solvents. Moreover, the crystal structure of the 
precursor, 2-cyanopyridine, was also unknown. This may be 
explained by the formation of micro-crystals, which are not 
suitable for single crystal X-ray diffraction. To that end, we 55 
herein report the crystal structures of 2-cyanopyrimidine and 
two polymorphs of TPymT, which were established through 
X-ray powder diffraction (XRPD) and synchrotron X-ray 
powder diffraction (SXRPD). The crystal structure of the 
main polymorph of TPymT was determined by single crystal 60 
X-ray diffraction (SCXRD). Additionally, we report a novel 
and more efficient synthetic route for the preparation of 
TPymT, along with SXRPD analysis of the intermediate, 
pyrimidine-2-carboximidamide. 
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Scheme 1 Preparation of α-TPymT and β-TPymT 
TPymT can be obtained via two different synthetic 
approaches as outlined in Scheme 1. The first involves 
trimerization of 2-cyanopyrimidine at 160 °C5 affording 
TPymT in 17% yield. Alternatively, TPymT can be prepared 70 
by heating 2-cyanopyrimidine under pressure in the presence 
of pyrimidine-2-carboximidamide, which was synthesized by 
heating a solution of 2-cyanopyrimidine and ammonia under 
Page 1 of 6 CrystEngComm
 2  |  Journal Name, [year], [vol], 00–00 This journal is © The Royal Society of Chemistry [year] 
pressure for several days. While TPymT can be prepared 
following both synthetic sequences, the latter approach 
resulted in significantly higher yields (60% vs. 17%) and 
cleaner crude material. We therefore suggest this finding as a 
new highly efficient synthetic approach for TPymT. 5 
Interestingly, the first synthetic route (i.e., trimerization of 2-
cyanopyrimidine) leads to the formation of a single 
polymorph α-TPymT, whereas the second pathway affords a 
mixture of two polymorphs α-TPymT and β-TPymT.  
The isolated compounds were initially characterized by 10 
FTIR and NMR spectroscopy. The FTIR spectra of 2-
cyanopyrimidine, pyrimidine-2-carboximidamide and TPymT 
each contain an intense band for the C=N stretches centred at 
about 1580 cm–1 (Fig. 1). The aromatic C–H groups in the 
spectra of the latter two compounds were found as a band at 15 
3060 cm–1, while the same stretches as well as a band for the 
C≡N group in the spectrum of 2-cyanopyrimidine are too 
weak to be clearly observed. The spectrum of pyrimidine-2-
carboximidamide also exhibits a set of intense bands for the 
NH and NH2 groups at 1660, 3110, 3290 and 3412 cm
–1. 20 
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Fig. 1 FTIR spectra of 2-cyanopyrimidine (black), pyrimidine-2-
carboximidamide (red) and TPymT (blue). 
The 1H NMR spectra of 2-cyanopyrimidine, pyrimidine-2-
carboximidamide and TPymT in DMSO-d6 each exhibit peaks 25 
for the pyrimidine fragment at 7.63–7.87 and 8.95–9.16 ppm. 
The spectrum of pyrimidine-2-carboximidamide also contains 
a broad singlet peak for the NH and NH2 protons at 7.12 ppm. 
The 13C NMR spectra of 2-cyanopyrimidine and pyrimidine-
2-carboximidamide each contain four peaks. Due to the low 30 
solubility of TPymT in organic solvents, 13C NMR was not 
possible. 
To shed light on the electronic properties of 2-
cyanopyrimidine, pyrimidine-2-carboximidamide and 
TPymT, diffuse reflectance spectra were recorded (Fig. 2). 35 
These spectra exhibit a broad band with several maxima in the 
UV region corresponding to intra-ligand transitions. The 
spectra of pyrimidine-2-carboximidamide and TPymT 
additionally contain a shoulder in the visible range at 375–600 
nm, which is responsible for the observed beige colour of 40 
these compounds. 
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Fig. 2 Normalized Kubelka-Munk spectra of 2-cyanopyrimidine (black), 
pyrimidine-2-carboximidamide (red) and TPymT (blue). 
In order to elucidate the molecular structures of 2-45 
cyanopyrimidine and pyrimidine-2-carboximidamide as well 
as their spatial arrangement in the crystalline lattice, 
synchrotron radiation powder X-ray studies were conducted 
(Fig. 3, Tables S1 and S2 in ESI†). Obtained powder patterns 
were solved in the orthorhombic P212121 (2-cyanopyrimidine) 50 
and triclinic P–1 (pyrimidine-2-carboximidamide) space 
groups. The asymmetric units of 2-cyanopyrimidine and 
pyrimidine-2-carboximidamide each contain one molecule. 
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Fig. 3 Rietveld refinement plots (λ = 0.68884 Å) of 2-cyanopyrimidine 
(top) and pyrimidine-2-carboximidamide (bottom). Experimental and 
calculated data are shown in red symbols and black line, respectively. 
Blue line shows the difference curve, while green marks show Bragg 
positions. Insets show molecular structures of 2-cyanopyrimidine and 5 
pyrimidine-2-carboximidamide. 
With respect to the packing of 2-cyanopyrimidine, the 
molecules form zigzag-like layers (Fig. 4). Molecules of 
pyrimidine-2-carboximidamide form parallel ribbons along 
the b axis via intermolecular N–H···N hydrogen bonds (Fig. 5, 10 
Table S3 in ESI†). Positions of the hydrogen atoms, 
determined from XRPD, are often inaccurate; however, based 
on the positions of non-hydrogen atoms we assume that the 
C=NH hydrogen atom is not involved in the hydrogen bond 
formation due to the lack of neighbouring acceptor atoms. The 15 
ribbons are further linked through weak π···π stacking 
interactions (Table S4 in ESI†). 
 
Fig. 4 Zigzag-like layers in the crystal packing of 2-cyanopyrimidine 
along the a (top) and b (bottom) axes. 20 
 
Fig. 5 A ribbon-like structure, formed due to intermolecular hydrogen 
bonds, in the crystal packing of pyrimidine-2-carboximidamide along the 
b axis. 
The crystal structure of α-TPymT was initially solved 25 
using ab initio from XRPD data of the sample obtained via the 
trimerization reaction using direct space Monte Carlo methods 
and refined by the Rietveld method. The experimental powder 
pattern was indexed easily and unambiguously due to the 
presence of one phase in the sample. However, choice of the 30 
space group remained ambiguous since P31, P61 and P3121 
space groups have a similar fit in the Le Bail refinement. 
Numerous attempts were therefore taken to solve the structure 
in these three space groups and the best results for each space 
group have been selected. The crystal structure refinement 35 
was further complicated by the preferred orientation; 
nevertheless, the final structure from XRPD data was refined 
in the P31 space group (for additional discussion about the 
choice of a space group see ESI†). 
In order to confirm this assignment, single crystal X-ray 40 
analysis was required. After numerous attempts,  crystals of α-
TPymT suitable for SCXRD were produced directly from the 
trimerization of 2-cyanopyrimidine. However, even the best 
selected crystal only diffracted up to 1.0 Å–1. Thus the 
structural model determined from XRPD was used as the 45 
initial starting point in the single-crystal data refinement. This 
model, in the P31 space group, was tested for any missing 
symmetry elements in PLATON8 and a two-fold axis was 
found. The space group was therefore changed to P3121 and 
applied to the final structure refinement. 50 
The asymmetric unit of α-TPymT contains two 
independent halves of two molecules (Fig. 6, Table S5 in 
ESI†) and the two-fold axis generates the remaining halves to 
complete the molecules. The crystal structure consists of 
alternating flat layers, packed orthogonal to the с axis. The 55 
torsion angles between the planes, formed by the triazine and 
pyrimidine rings, are –24(4), –24(4) and 36.2(14)° in one 
molecule and –37(4), 21.8(14) and 21.8(14)° in the other. 
 
Fig. 6 Molecular structure of two independent molecules of α-TPymT. 60 
Symmetry codes: i: 1 + x – y, 2 – y, 2/3 – z; ii: –x, –x + y, 1/3 – z. 
The two symmetry independent molecules in α-TPymT 
each produce two sets of layers; however, they are very 
similar and only differ slightly with respect to the orientation 
of the pyrimidine rings relative to the triazine ring (Fig. 7). 65 
The interlayer distances are approximately 3.53 and 3.63 Å, 
which is slightly offset (± 1.3%) from that of c/6 = 3.578 Å. 
Such a layered structure leads to the appearance of a preferred 
orientation in the experimental XRPD. 
Before obtaining single crystals of TPymT, we tried to 70 
determine a more detailed structure of TPymT using SXRPD 
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data, which was collected from a sample obtained by the 
reaction of 2-cyanopyrimidine with pyrimidine-2-
carboximidamide. From this sample, the diffraction pattern 
revealed the same peaks as were observed for the α-TPymT 
polymorph as well as several additional peaks that did not 5 
match the α-TPymT unit cell. These peaks were successfully 
indexed in the monoclinic system (Fig. 8), suggesting that the 
second monoclinic phase corresponds to another polymorph β-
TPymT. This assumption is based on the following 
arguments: i) if the unit cell of the second phase contains two 10 
independent molecules, then its volume per molecule is very 
close to that of α-TPymT (341.16 and 334.08 Å3 for α- and β-
polymorphs, respectively); ii) some of the unit cell parameters 
are similar, indicating the similarity between these phases; iii) 
comparison of the XRPD patterns of the two phases shows 15 
that the peaks of the second phase β-TPymT do not 
correspond to the starting materials 2-cyanopyrimidine and 
pyrimidine-2-carboximidamide (Fig. 3) or other possible 
impurities, which was further confirmed by IR and NMR data. 
 20 
Fig. 7 Crystal packing of α-TPymT along the b axis (H-atoms were 
omitted for clarity). Symmetry independent molecules are shown in 
different colours. 
Analysis of systematic absences of reflections has shown 
that the structure of β-TPymT does not contain any glide 25 
planes, limiting a choice of the possible space group to P2, 
P21, Pm, P2/m and P21/m. Furthermore, unless TPymT is flat, 
a mirror plane in the structure is unlikely to be compatible 
with the molecular symmetry. This therefore narrows the 
choice of the space group for β-TPymT to P2 or P21. Based 30 
on the reflection intensities of the two phases, the content of 
β-TPymT can be roughly estimated to ~10%. 
We assume that the sample obtained by reacting 2-
cyanopyrimidine with pyrimidine-2-carboximidamide is an 
example of polytypism, which is a special case of 35 
polymorphism of layered structures when the two-dimensional 
translations within the layers are essentially preserved. Each 
polymorph of this type can be regarded as built up by stacking 
layers of a nearly identical structure, and they differ only in 
their stacking sequence. In our case, TPymT molecules form 40 
such layers in α-TPymT (Fig. 7) and, based on the unit cell 
parameters, also in β-TPymT. In both polymorphs, the 
molecules of TPymT are almost parallel to the ac plane. This 
might result in close values of interplanar spacings and lead to 
a significant overlap of diffraction peaks from the two phases. 45 
Such an overlap, accompanied with the preferred orientation, 
makes it impossible to extract intensities of peaks for two 
crystalline phases and, hence, to solve the structure of β-
TPymT from SXRPD data. 
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Fig. 8 Le Bail fit to the synchrotron radiation X-ray powder pattern (λ = 
0.821693 Å) of the sample obtained by the reaction of 2-cyanopyrimidine 
with pyrimidine-2-carboximidamide. Experimental and calculated data 
are shown in red symbols and black line, respectively. Blue line shows 
the difference curve, while green marks show Bragg positions for α-55 
TPymT (top row) and β-TPymT (bottom row). 
In summary, for the first time we have obtained the crystal 
structure of TPymT and determined that it crystallizes in the 
trigonal P3121 space group to produce the polymorph α-
TPymT. It was also established that the polymorph α-TPymT 60 
is the only product formed during the trimerization reaction of 
2-cyanopyrimidine, while the reaction of 2-cyanopyrimidine 
with pyrimidine-2-carboximidamide leads to a mixture of α-
TPymT and a second polymorph β-TPymT. Crystal 
structures of the precursors 2-cyanopyrimidine and 65 
pyrimidine-2-carboximidamide were also elucidated by 
SXRPD. These results are critical to understanding the 
supramolecular arrangement and packing of TPymT. 
Furthermore, the new, more efficient synthetic route for the 
isolation of TPymT opens an important avenue for large scale 70 
synthesis as well as its use in coordination chemistry as a 
counterpart for terpy or pyrimidine ligand systems. 
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Physical measurements 
Infrared spectra were recorded with a Varian 640 FTIR 
spectrometer equipped with an ATR in the 500–4000 cm–1 
range. 1H and 13C NMR spectra in DMSO-d6 were obtained on 
a Bruker Avance 300 MHz spectrometer at 25 °C. Diffuse 5 
reflectance spectra were obtained with a Varian Cary 100 
spectrometer using polytetrafluoroethylene (PTFE) as a 
reference. Kubelka-Munk spectra were normalized to allow 
meaningful comparisons. 
2-Cyanopyrimidine 10 
M. p.: 40–44 °C. 1H NMR, δ: 7.87 (t, 3JH,H = 5.0 Hz, 1H, p-
CH, pyrimidine), 9.02 (d, 3JH,H = 5.0 Hz, 2H, m-CH, 
pyrimidine) ppm. 13C NMR, δ: 115.91, 124.76, 143.94, 158.72 
ppm. 
Synthesis of pyrimidine-2-carboximidamide 15 
In a glass pressure vessel, ammonia gas (Linde) was bubbled 
through a solution of 2-cyanopyrimidine (95.1 mmol, 10.0 g; 
Oakwood Chemicals) in 100 mL MeCN (distilled over P2O5, 
stored on 4 Å molecular sieves) cooled on an ice bath for 
approximately 30 min. The flask was then sealed and heated 20 
at 110 °C for 3 days. The resulting red solution was cooled to 
room temperature, the vessel was carefully vented, and the 
brown crystalline solid of pyrimidine-2-carboximidamide was 
filtered off and washed with MeCN. Crude yield: 9.10 g 
(78%). Recrystallization from MeCN afforded pale beige 25 
needles. M. p.: 159–163 °C. 1H NMR, δ: 7.12 (br. s, 3H, 
NH+NH2), 7.63 (t, 
3JH,H = 4.9 Hz, 1H, p-CH, pyrimidine), 
8.95 (d, 3JH,H = 4.9 Hz, 2H, m-CH, pyrimidine) ppm. 
13C 
NMR, δ: 121.81, 156.16, 157.52, 159.64 ppm. Anal. Calcd. 
for C5H6N4: C, 49.17; H,4.95; N, 45.88. Found: C, 49.02; H, 30 
4.90; N, 45.60. 
Synthesis of α-TPymT 
α-TPymT was obtained using the synthetic procedure 
described by Lerner and Lippard;2 however, the yield was 
much lower than reported regardless of the reaction time. 2-35 
Cyanopyrimidine (52 mmol, 5.5 g) was heated with stirring in 
a stoppered flask at 160 °C for 72 h. The resulting product 
was washed with diethyl ether (5 × 20 mL) to remove 
unreacted starting material. Yield: 0.96 g (17%). M. p.: >350 
°C. 1H NMR, δ: 7.82 (t, 3JH,H = 4.8 Hz, 3H, p-CH, 40 
pyrimidine), 9.16 (d, 3JH,H = 4.8 Hz, 6H, m-CH, pyrimidine) 
ppm. 
Synthesis of α-TPymT and β-TPymT 
To a glass pressure vessel under a blanket of N2(g), 
pyrimidine-2-carboximidamide (37.8 mmol, 4.62 g), 2-45 
cyanopyrimidine (75.5 mmol, 7.93 g) and 100 mL MeCN 
(distilled over P2O5, stored on 4 Å molecular sieves) were 
loaded. The vessel was sealed and heated at 110 °C for 5 days. 
The green-brown slurry was cooled to room temperature and 
filtered. The crude solid was washed in hot EtOAc to afford a 50 
beige powder. Yield: 7.17 g (60%). 
X-ray powder diffraction (XRPD) 
The XRPD pattern for the bulk sample of α-TPymT was 
measured using a Rigaku Ultima IV X-ray powder 
diffractometer (Cu-Kα radiation, graphite monochromator, 55 
scintillation counter). The parallel beam mode was used to 
collect the data. Powder pattern was indexed in 
trigonal/hexagonal crystal system using the DICVOL04 
program.9 Crystal structure was solved using direct space 
methods with the FOX program10 and refined by the Rietveld 60 
method using the Fullprof suite.11 Initial molecular model was 
constructed in the Mercury 3.0 program,12 using the 2,4,6-
tris(4-pyridyl)-1,3,5-triazine molecule13 as a starting model, 
which was modifed. The preferred orientation, using the 
March-Dollase model for the (100) direction, and antibump 65 
restraints for the H···H distances (d(H···H) > 2.25 Å), was 
introduced at the final stage of the refinement. 
α-TPymT. C15H9N9, Mr = 315.31 g·mol
−1, trigonal, space 
group P31, a = 10.42385(17), c = 21.7533(2) Å, V = 
2046.98(8) Å3, Z = 6, Z' = 2, ρ = 1.535 g cm−3, µ(Cu-Kα) = 70 
0.853 mm−1, Rp = 0.1392, Rwp = 0.1817, RI = 0.1347. 
Single-crystal X-ray diffraction (SCXRD) 
Inhouse data for α-TPymT were collected on a MAR345 
image plate using Mo Kα radiation focused by a Xenocs 
Fox3D mirror at 150 K. Few crystals were tested and the best 75 
available dataset were chosen. The data were integrated using 
the CrysAlisPro14 software and the multi-scan absorption 
correction was applied. Data was cut off up to 1.0 Å–1. The 
structural model was refined by full-matrix least squares on 
|F|2 using SHELXL-201415 and the shelXLe shell.16 Relative 80 
restrains on the C–C distances were used to make all length of 
bonds between pyrimidine and triazine ring simular to each 
other. All non-hydrogen atoms were refined anisotropically, 
but restrains were applied on thermal parameters. Hydrogen 
atoms were placed on calculated positions in riding mode with 85 
temperature factors fixed at 1.2 times Ueq of the parent atoms. 
Two-component inversion twinning was introduced at the 
final stage of the refinement. 
α-TPymT. C15H9N9, Mr = 315.31 g·mol
−1, trigonal, space 
group P3121, a = 10.4339(10), c = 21.467(2) Å, V = 2023.9(4) 90 
Å3, Z = 6, ρ = 1.552 g cm−3, µ(Mo Kα) = 0.105 mm−1, 
reflections: 1408 unique, Rint = 0.084, R1(all) = 0.1119 
wR2(all) = 0.3366. 
Synchrotron X-ray powder diffraction (SXRPD) 
The SXRPD patterns for the bulk sample of a mixture of α-95 
TPymT and β-TPymT, 2-cyanopyrimidine and pyrimidine-2-
carboximidamide were measured on the Swiss-Norwegian 
beamline BM1A at the European Synchrotron Radiation 
Facility (transmittion geometry, PILATUS 2M pixel detector, 
λ = 0.821693 Å for a mixture of α-TPymT and β-TPymT, and 100 
λ = 0.68884 Å for 2-cyanopyrimidine and pyrimidine-2-
carboximidamide). Powder patterns were indexed using the 
FOX program.10 Crystal structures were solved using direct 
space methods with the FOX program10 and refined by the 
Rietveld method using the Fullprof suite.11 Initial molecular 105 
models were constructed in the Mercury 3.0 program,12 using 
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the corresponding molecular fragment based on the single-
crystal structural models taken from the Cambridge Structural 
Database (QOFBUJ17 for 2-cyanopyrimidine and 
CONYAF1018 for pyrimidine-2-carboximidamide). The 
preferred orientation in the March-Dollase model for the (011) 5 
direction was introduced at the final stage of the structure 
determination for 2-cyanopyrimidine. 
2-cyanopyrimidine. C5H3N3, Mr = 105.10 g·mol
−1, 
orthorhombic, space group P212121, a = 3.97105(6), b = 
8.12770(14), c = 16.0709(3) Å, V = 518.696(16) Å3, Z = 4, ρ 10 
= 1.346 g cm−3, µ(λ = 0.68884 Å) = 0.084 mm−1, Rp = 0.0241, 
Rwp = 0.0274, RI = 0.1115. 
pyrimidine-2-carboximidamide. C5H6N4, Mr = 122.14 
g·mol−1, triclinic, space group P–1, a = 5.55795(14), b = 
7.25941(12), c = 7.7260(2) Å, α = 84.431(2), β = 71.913(3), γ 15 
= 80.163(2)°, V = 291.643(12) Å3, Z = 2, ρ = 1.391 g cm−3, 
µ(λ = 0.68884 Å) = 0.089 mm−1, Rp = 0.0639, Rwp = 0.0683, RI 
= 0.1630. 
β-TPymT. C15H9N9, Mr = 315.31 g·mol
−1, monoclinic, a = 
9.00415(12), b = 3.40734(4), c = 21.9848(4) Å, β = 20 
97.8648(10)°, V = 668.152(16) Å3, Z = 2, ρ = 1.567 g cm−3. 
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